- Pharmaceutical industry | Definition, Overview, History . . .
The pharmaceutical industry entails the discovery, development, and manufacture of drugs and medications (pharmaceuticals) by public and private organizations
- Sackler family | Brothers, OxyContin, Purdue Pharma, Opioid Epidemic . . .
The Sackler family formerly owned the pharmaceutical company Purdue Pharma, known for developing the highly addictive drug OxyContin They gave up control of the company in 2025 as part of a settlement for their involvement in the opioid epidemic
- Aventis | Pharmaceuticals, Healthcare, Merger | Britannica Money
Aventis, former French pharmaceutical company founded in 1999 through the merger of the German firm Hoechst and the French company Rhône-Poulenc With headquarters in Strasbourg, France, Aventis was the product of the first transnational merger to combine large rival companies from France and Germany It became part of the French pharmaceutical conglomerate Sanofi-Aventis in 2004
- Dilip Shanghvi | Biography Facts | Britannica Money
The son of a wholesale drug distributor, Shanghvi launched Sun Pharma soon after graduating (1982) from the University of Calcutta with a bachelor’s degree in commerce
- Sanofi-Aventis | Pharmaceuticals, Vaccines, Biotechnology | Britannica . . .
Sanofi-Aventis, French pharmaceutical company founded in 2004 through the merger of Sanofi-Synthélabo
- Johnson Johnson | History, Products, Controversies | Britannica Money
Johnson Johnson is the world’s second largest drug and biotechnology company by market capitalization, behind Eli Lilly (LLY) but ahead of other “big pharma” competitors such as AbbVie (ABBV), Novartis (NVS), and Merck (MRK)
- Luigi Mangione | CEO Murder Suspect, Health Care Protests, Notoriety . . .
Luigi Mangione is the accused killer of UnitedHealthcare CEO Brian Thompson, who was gunned down in New York City on December 4, 2024 The juxtaposition of Mangione’s youth, good looks, and privileged upbringing with what is seen by some as an act of protest against corporate greed made him a cause célèbre
- Pharmaceuticals, Vaccines, Facts - Britannica Money
Like most “big pharma” companies, AstraZeneca’s future depends on its ability to: Maintain a pipeline of new and improved treatments in order to manage its revenue streams as patents for its key drugs expire The company has upped its R D spending in recent years, spending nearly $11 billion in 2023 on its pipeline of over 150 projects
|